Multidisciplinary Management of Breast Cancer Brain Metastases
- PMID: 27753060
Multidisciplinary Management of Breast Cancer Brain Metastases
Abstract
This review summarizes the most up-to-date approach to the multidisciplinary management of patients with breast cancer brain metastases. A brief overview of the epidemiology and biology of breast cancer brain metastasis is provided. The perspectives of radiation oncology, neurosurgery, and medical oncology-and landmark studies from each discipline-are all discussed. We also offer practical tips to help guide the treating physician, including data on antiseizure medications. Finally, we introduce the concept of a multidisciplinary clinic that combines input from medical and radiation oncology, neurosurgery, and support services, which we developed at the University of North Carolina as a coordinated and optimal approach to the management of patients with this complex disease.
Comment in
-
Breast Cancer Brain Metastasis: An Ongoing Clinical Challenge and Opportunity for Innovation.Oncology (Williston Park). 2016 Oct 15;30(10):934-5. Oncology (Williston Park). 2016. PMID: 27753061 No abstract available.
Similar articles
-
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.Oncologist. 2016 Jan;21(1):16-20. doi: 10.1634/theoncologist.2015-0328. Epub 2015 Dec 9. Oncologist. 2016. PMID: 26659221 Free PMC article.
-
[Global brain metastases management strategy: a multidisciplinary-based approach].Cancer Radiother. 2015 Feb;19(1):61-5. doi: 10.1016/j.canrad.2014.11.009. Epub 2015 Jan 31. Cancer Radiother. 2015. PMID: 25649388 Review. French.
-
Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm.Clin Transl Oncol. 2020 Oct;22(10):1698-1709. doi: 10.1007/s12094-020-02333-7. Epub 2020 Mar 21. Clin Transl Oncol. 2020. PMID: 32207041 Review.
-
[Complex treatment of breast cancer patients with brain metastases].Vopr Onkol. 2015;61(6):965-7. Vopr Onkol. 2015. PMID: 26995988 Clinical Trial. Russian.
-
Brain metastases in breast cancer: prognostic factors and management.Breast Cancer Res Treat. 2008 Oct;111(3):523-30. doi: 10.1007/s10549-007-9806-2. Epub 2007 Nov 8. Breast Cancer Res Treat. 2008. PMID: 17990100
Cited by
-
Breast cancer brain metastasis: molecular mechanisms and directions for treatment.Neuro Oncol. 2018 Oct 9;20(11):1439-1449. doi: 10.1093/neuonc/noy044. Neuro Oncol. 2018. PMID: 29566179 Free PMC article. Review.
-
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases.Future Oncol. 2019 Jul;15(19):2211-2225. doi: 10.2217/fon-2019-0180. Epub 2019 May 10. Future Oncol. 2019. PMID: 31074641 Free PMC article. Clinical Trial.
-
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.BMC Cancer. 2018 Jan 25;18(1):97. doi: 10.1186/s12885-018-3994-5. BMC Cancer. 2018. PMID: 29370839 Free PMC article.
-
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer.Int J Clin Oncol. 2024 Apr;29(4):427-441. doi: 10.1007/s10147-024-02472-9. Epub 2024 Feb 27. Int J Clin Oncol. 2024. PMID: 38411882
-
Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study.Breast J. 2022 Aug 19;2022:5763810. doi: 10.1155/2022/5763810. eCollection 2022. Breast J. 2022. PMID: 36051468 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical